Nexus of Pathophysiology & Therapeutics Journal (NPT)
This is the official journal for mechanistic pathophysiology and translational therapeutic research, and a leading journal advancing the mechanistic understanding of disease and translating molecular and cellular insights into therapeutic innovation and precision medicine.
Keyword Index
B
  • B signaling pathway Targeting Inflammatory Pathways: Are We Entering a New Era of Mechanism-Driven Therapeutics? [Volume 1, Issue 1, 2026, Pages 1-6]
C
  • Cross-disease Biology From Mechanism to Intervention: The Scope of Nexus of Pathophysiology and Therapeutics [Volume 1, Issue 1, 2026, Pages 1-4]
  • Cytokine signaling networks Targeting Inflammatory Pathways: Are We Entering a New Era of Mechanism-Driven Therapeutics? [Volume 1, Issue 1, 2026, Pages 1-6]
  • Cytokine Storm Endothelial Dysfunction and Immune Dysregulation in Hantavirus Infection: Mechanisms of Vascular Leakage and Disease Severity [Volume 1, Issue 1, 2026, Pages 1-7]
E
  • Endothelial dysfunction Endothelial Dysfunction and Immune Dysregulation in Hantavirus Infection: Mechanisms of Vascular Leakage and Disease Severity [Volume 1, Issue 1, 2026, Pages 1-7]
  • Endothelial dysfunction Hantavirus Pathophysiology: Insights from Tissue and Cellular Perspectives [Volume 1, Issue 1, 2026, Pages 1-5]
H
  • Hantavirus Endothelial Dysfunction and Immune Dysregulation in Hantavirus Infection: Mechanisms of Vascular Leakage and Disease Severity [Volume 1, Issue 1, 2026, Pages 1-7]
  • Hantavirus Hantavirus Pathophysiology: Insights from Tissue and Cellular Perspectives [Volume 1, Issue 1, 2026, Pages 1-5]
I
  • Immune response Hantavirus Pathophysiology: Insights from Tissue and Cellular Perspectives [Volume 1, Issue 1, 2026, Pages 1-5]
  • Immunopathogenesis Endothelial Dysfunction and Immune Dysregulation in Hantavirus Infection: Mechanisms of Vascular Leakage and Disease Severity [Volume 1, Issue 1, 2026, Pages 1-7]
  • Inflammation Targeting Inflammatory Pathways: Are We Entering a New Era of Mechanism-Driven Therapeutics? [Volume 1, Issue 1, 2026, Pages 1-6]
J
  • Janus kinase (JAK) inhibitors Targeting Inflammatory Pathways: Are We Entering a New Era of Mechanism-Driven Therapeutics? [Volume 1, Issue 1, 2026, Pages 1-6]
M
  • MCV Alterations in Red Blood Cell Indices in Preeclampsia and Their Potential Clinical and Translational Implications [Volume 1, Issue 1, 2026, Pages 1-11]
N
  • NF-&kappa Targeting Inflammatory Pathways: Are We Entering a New Era of Mechanism-Driven Therapeutics? [Volume 1, Issue 1, 2026, Pages 1-6]
  • NLRP3 inflammasome Targeting Inflammatory Pathways: Are We Entering a New Era of Mechanism-Driven Therapeutics? [Volume 1, Issue 1, 2026, Pages 1-6]
O
  • Oxidative Stress and Inflammation Alterations in Red Blood Cell Indices in Preeclampsia and Their Potential Clinical and Translational Implications [Volume 1, Issue 1, 2026, Pages 1-11]
P
  • Pathogenesis Hantavirus Pathophysiology: Insights from Tissue and Cellular Perspectives [Volume 1, Issue 1, 2026, Pages 1-5]
R
  • RDW Alterations in Red Blood Cell Indices in Preeclampsia and Their Potential Clinical and Translational Implications [Volume 1, Issue 1, 2026, Pages 1-11]
  • Red Blood Cell Indices Alterations in Red Blood Cell Indices in Preeclampsia and Their Potential Clinical and Translational Implications [Volume 1, Issue 1, 2026, Pages 1-11]
T
  • Therapeutic Interpretation From Mechanism to Intervention: The Scope of Nexus of Pathophysiology and Therapeutics [Volume 1, Issue 1, 2026, Pages 1-4]
  • Translational Medicine From Mechanism to Intervention: The Scope of Nexus of Pathophysiology and Therapeutics [Volume 1, Issue 1, 2026, Pages 1-4]
V
  • Vascular Permeability Endothelial Dysfunction and Immune Dysregulation in Hantavirus Infection: Mechanisms of Vascular Leakage and Disease Severity [Volume 1, Issue 1, 2026, Pages 1-7]
  • Vascular Permeability Hantavirus Pathophysiology: Insights from Tissue and Cellular Perspectives [Volume 1, Issue 1, 2026, Pages 1-5]